NAIROBI, Kenya, Dec 31 – The Social Health Authority (SHA) has announced that licensed overseas healthcare providers can now offer specialized medical treatments unavailable in Kenya.
The move aims to expand access to advanced care for beneficiaries under the Social Health Insurance Fund (SHIF) and the Public Officers Medical Scheme Fund (POMSF) for the 2025–2026 period.
The SHA contracting process covers a comprehensive range of services, including:
- Laboratory investigations and diagnostic imaging
- Medical treatment and interventions
- Patient accommodation and transfers
- Post-treatment care
SHA has invited Expressions of Interest (EOI) from qualified overseas providers within 14 days of the notice.
“The Authority is seeking overseas healthcare providers with demonstrated capacity to deliver medical interventions not readily available in the country,” SHA said in the invitation notice.
The Social Health Authority (SHA) has invited Expressions of Interest from licensed overseas healthcare providers to offer highly specialised medical treatments not available in Kenya, for SHA beneficiaries under SHIF and POMSF, covering the 2025–2026 period.The contracting
The initiative is anchored under the Emergency, Chronic, and Critical Illness Fund (ECCIF) and governed by the Public Finance Management Act (Public Officers Medical Scheme Fund) Regulations, Legal Notice 195 of 2024.
SHA will align overseas treatments with procedures identified by the Benefits Package and Tariffs Advisory Panel (BPTAP) under Legal Notice No. 5044, ensuring that only services not available locally are contracted abroad.
POMSF beneficiaries will access specialized treatments upon referral, with costs negotiated directly between SHA and the overseas healthcare provider.
Eligible healthcare providers must submit:
- Proof of registration
- A valid Power of Attorney authorizing the signatory
- A detailed price list for services offered, following SHA guidelines
The move is part of SHA’s mandate to ensure that Kenyans requiring advanced medical procedures can receive timely, quality treatment beyond national borders.



